natgillin/translations-raw huggingface dataset:
Cytochromes P450-CYP1A2 and P450-CYP2D6 contribute to the formation of the N-desmethyl and 2-hydroxymethyl metabolites, both exhibited significantly less in vivo pharmacological activity than olanzapine in animal studies.
Bildningen av N-desmetyl- och 2-hydroximetylmetaboliterna sker via cytokromerna P450-CYP1A2 och P450-CYP2D6.
INFORMATION IN BRAILLE Olanzapine Teva 10 mg orodispersible tablets
INFORMATION I PUNKTSKRIFT Olanzapine Teva 10 mg munlösliga tabletter
Each Olanzapine Teva 15 mg film-coated tablet contains 15 mg of the active substance.
Varje Olanzapine Teva 15 mg filmdragerad tablett innehåller 15 mg av den aktiva substansen.
Each Olanzapine Teva 15 mg orodispersible tablet contains 15 mg of the active substance.
Varje Olanzapine Teva 15 mg munlöslig tablett innehåller 15 mg av den aktiva substansen.
OPA-Al-PVC/Al blisters in cartons of 28, 30, 35, 50, 56, 70 or 98 orodispersible tablets per carton.
OPA/Aluminium/PVC-aluminium-blisterförpackningar i kartonger om 28, 30, 35, 50, 56, 70 eller 98 munlösliga tabletter per kartong.
NAME OF THE MEDICINAL PRODUCT Olanzapine Teva 20 mg orodispersible tablets Olanzapine
LÄKEMEDLETS NAMN Olanzapine Teva 20 mg munlösliga tabletter olanzapin
Olanzapine Teva 7.5 mg film-coated tablets EU/1/07/427/008 - 28 tablets, per box EU/1/07/427/077 - 28 x 1 tablets, per box EU/1/07/427/009 - 30 tablets, per box EU/1/07/427/078 - 30 x 1 tablets, per box EU/1/07/427/040 - 35 tablets, per box EU/1/07/427/079 - 35 x 1 tablets, per box EU/1/07/427/010 - 56 tablets, per box EU/1/07/427/080 - 56 x 1 tablets, per box EU/1/07/427/068 - 60 tablets, per box EU/1/07/427/050 - 70 tablets, per box EU/1/07/427/081 - 70 x 1 tablets, per box EU/1/07/427/060 - 98 tablets, per box EU/1/07/427/082 - 98 x 1 tablets, per box
Olanzapine Teva 7,5 mg filmdragerade tabletter EU/1/07/427/008 - 28 tabletter per kartong EU/1/07/427/077 - 28 x 1 tabletter per kartong EU/1/07/427/009 - 30 tabletter per kartong EU/1/07/427/078 - 30 x 1 tabletter per kartong EU/1/07/427/040 - 35 tabletter per kartong EU/1/07/427/079 - 35 x 1 tabletter per kartong EU/1/07/427/010 - 56 tabletter per kartong EU/1/07/427/080 - 56 x 1 tabletter per kartong EU/1/07/427/068 - 60 tabletter per kartong EU/1/07/427/050 - 70 tabletter per kartong EU/1/07/427/081 - 70 x 1 tabletter per kartong EU/1/07/427/060 - 98 tabletter per kartong EU/1/07/427/082 - 98 x 1 tabletter per kartong
Olanzapine Teva 15 mg film-coated tablets are available in cartons of 28, 30, 35, 50, 56, 70 or 98 filmcoated tablets.
Olanzapine Teva 15 mg filmdragerade tabletter tillhandahålls i förpackningar med 28, 30, 35, 50, 56, 70 eller 98 tabletter.
INFORMATION IN BRAILLE Olanzapine Teva 5 mg orodispersible tablets
INFORMATION I PUNKTSKRIFT Olanzapine Teva 5 mg munlösliga tabletter
Olanzapine Teva 10 mg film-coated tablets EU/1/07/427/011 - 7 tablets, per box EU/1/07/427/083 - 7 x 1 tablets, per box EU/1/07/427/012 - 28 tablets, per box EU/1/07/427/084 - 28 x 1 tablets, per box EU/1/07/427/013 - 30 tablets, per box EU/1/07/427/085 - 30 x 1 tablets, per box EU/1/07/427/041 - 35 tablets, per box EU/1/07/427/086 - 35 x 1 tablets, per box EU/1/07/427/014 - 50 tablets, per box EU/1/07/427/087 - 50 x 1 tablets, per box EU/1/07/427/015 - 56 tablets, per box EU/1/07/427/088 - 56 x 1 tablets, per box EU/1/07/427/069 - 60 tablets, per box EU/1/07/427/051 - 70 tablets, per box EU/1/07/427/089 - 70 x 1 tablets, per box EU/1/07/427/061 - 98 tablets, per box EU/1/07/427/090 - 98 x 1 tablets, per box
Olanzapine Teva 10 mg filmdragerade tabletter EU/1/07/427/011 - 7 tabletter per kartong EU/1/07/427/083 - 7 x 1 tabletter per kartong EU/1/07/427/012 - 28 tabletter per kartong EU/1/07/427/084 - 28 x 1 tabletter per kartong EU/1/07/427/013 - 30 tabletter per kartong EU/1/07/427/085 - 30 x 1 tabletter per kartong EU/1/07/427/041 - 35 tabletter per kartong EU/1/07/427/086 - 35 x 1 tabletter per kartong EU/1/07/427/014 - 50 tabletter per kartong EU/1/07/427/087 - 50 x 1 tabletter per kartong EU/1/07/427/015 - 56 tabletter per kartong EU/1/07/427/088 - 56 x 1 tabletter per kartong EU/1/07/427/069 - 60 tabletter per kartong EU/1/07/427/051 - 70 tabletter per kartong EU/1/07/427/089 - 70 x 1 tabletter per kartong
NAME OF THE MEDICINAL PRODUCT Olanzapine Teva 2.5 mg film-coated tablets Olanzapine
LÄKEMEDLETS NAMN Olanzapine Teva 2,5 mg filmdragerade tabletter olanzapin
INFORMATION IN BRAILLE Olanzapine Teva 15 mg film-coated tablets
INFORMATION I PUNKTSKRIFT Olanzapine Teva 15 mg filmdragerade tabletter
INFORMATION IN BRAILLE Olanzapine Teva 15 mg orodispersible tablets
INFORMATION I PUNKTSKRIFT Olanzapine Teva 15 mg munlösliga tabletter
Each Olanzapine Teva 5 mg film-coated tablet contains 5 mg of the active substance.
Varje Olanzapine Teva 5 mg filmdragerad tablett innehåller 5 mg av den aktiva substansen.
INFORMATION IN BRAILLE Olanzapine Teva 10 mg film-coated tablets
INFORMATION I PUNKTSKRIFT Olanzapine Teva 10 mg filmdragerade tabletter
NAME OF THE MEDICINAL PRODUCT Olanzapine Teva 20 mg film-coated tablets Olanzapine
LÄKEMEDLETS NAMN Olanzapine Teva 20 mg filmdragerade tabletter olanzapin
Olanzapine Teva 5 mg film-coated tablets EU/1/07/427/004 - 28 tablets, per box EU/1/07/427/070 - 28 x 1 tablets, per box EU/1/07/427/005 - 30 tablets, per box EU/1/07/427/071 - 30 x 1 tablets, per box EU/1/07/427/039 - 35 tablets, per box EU/1/07/427/072 - 35 x 1 tablets, per box EU/1/07/427/006 - 50 tablets, per box EU/1/07/427/073 - 50 x 1 tablets, per box EU/1/07/427/007 - 56 tablets, per box EU/1/07/427/074 - 56 x 1 tablets, per box EU/1/07/427/049 - 70 tablets, per box EU/1/07/427/075 - 70 x 1 tablets, per box EU/1/07/427/059 - 98 tablets, per box EU/1/07/427/076 - 98 x 1 tablets, per box
Olanzapine Teva 5 mg filmdragerade tabletter EU/1/07/427/004 - 28 tabletter per kartong EU/1/07/427/070 - 28 x 1 tabletter per kartong EU/1/07/427/005 - 30 tabletter per kartong EU/1/07/427/071 - 30 x 1 tabletter per kartong EU/1/07/427/039 - 35 tabletter per kartong EU/1/07/427/072 - 35 x 1 tabletter per kartong EU/1/07/427/006 - 50 tabletter per kartong EU/1/07/427/073 - 50 x 1 tabletter per kartong EU/1/07/427/007 - 56 tabletter per kartong EU/1/07/427/074 - 56 x 1 tabletter per kartong EU/1/07/427/049 - 70 tabletter per kartong EU/1/07/427/075 - 70 x 1 tabletter per kartong EU/1/07/427/059 - 98 tabletter per kartong EU/1/07/427/076 - 98 x 1 tabletter per kartong
Olanzapine Teva 15 mg film-coated tablet is a light blue, biconvex, oval film-coated tablet, debossed ”OL 15” on one side and plain on the other.
Olanzapine Teva 15 mg filmdragerade tabletter är ljusblå, bikonvexa, ovala, filmdragerade tabletter, präglade med ”OL 15” på en sida och omärkta på den andra.
Excipient with known effect Each film-coated tablet contains 71.3 mg lactose.
Varje filmdragerad tablett innehåller 71.3 mg laktos.
Each Olanzapine Teva 5 mg orodispersible tablet contains 5 mg of the active substance.
Varje Olanzapine Teva 5 mg munlöslig tablett innehåller 5 mg av den aktiva substansen.
28 film-coated tablets 30 film-coated tablets 35 film-coated tablets 50 film-coated tablets 56 film-coated tablets 70 film-coated tablets 98 film-coated tablets
28 fildragerade tabletter 30 fildragerade tabletter 35 fildragerade tabletter 50 fildragerade tabletter 56 fildragerade tabletter 70 fildragerade tabletter 98 filmdragerade tabletter
NAME OF THE MEDICINAL PRODUCT Olanzapine Teva 10 mg orodispersible tablets Olanzapine
LÄKEMEDLETS NAMN Olanzapine Teva 10 mg munlösliga tabletter olanzapin
Olanzapine Teva 2.5 mg film-coated tablets are available in cartons of 28, 30, 35, 56, 70 or 98 filmcoated tablets.
Olanzapine Teva 2,5 mg filmdragerade tabletter tillhandahålls i förpackningar med 28, 30, 35, 56, 70 eller 98 tabletter.
OPA-Al-PVC/Al blisters in cartons of 28, 30, 35, 56, 70 or 98 orodispersible tablets per carton.
OPA/Aluminium/PVC-aluminium-blisterförpackningar i kartonger om 28, 30, 35, 56, 70 eller 98 munlösliga tabletter per kartong.
Olanzapine Teva 10 mg film-coated tablet is a white, biconvex, round film-coated tablet, debossed ”OL 10” on one side and plain on the other.
Olanzapine Teva 10 mg filmdragerade tabletter är vita, bikonvexa, runda, filmdragerade tabletter, präglade med ”OL 10” på en sida och omärkta på den andra.
28 film-coated tablets 28 x 1 film-coated tablets 30 film-coated tablets 30 x 1 film-coated tablets 35 film-coated tablets 35 x 1 film-coated tablets 56 film-coated tablets 56 x 1 film-coated tablets 60 film-coated tablets 70 film-coated tablets 70 x 1 film-coated tablets 98 film-coated tablets 98 x 1 film-coated tablets
28 filmdragerade tabletter 28 x 1 filmdragerade tabletter 30 filmdragerade tabletter 30 x 1 filmdragerade tabletter 35 ilmdragerade tabletter 35 x 1 filmdragerade tabletter 56 filmdragerade tabletter 56 x 1 filmdragerade tabletter 60 filmdragerade tabletter 70 filmdragerade tabletter 70 x 1 filmdragerade tabletter 98 filmdragerade tabletter 98 x 1> filmdragerade tabletter
Olanzapine
Glykosuri
Elevated cholesterol levels2,3
Metabolism och nutrition Viktuppgång1 Förhöjd kolesterolnivå2, 3
INFORMATION IN BRAILLE Olanzapine Teva 5 mg film-coated tablets
INFORMATION I PUNKTSKRIFT Olanzapine Teva 5 mg filmdragerade tabletter
NAME OF THE MEDICINAL PRODUCT Olanzapine Teva 15 mg orodispersible tablets Olanzapine
LÄKEMEDLETS NAMN Olanzapine Teva 15 mg munlösliga tabletter olanzapin
STATEMENT OF ACTIVE SUBSTANCE(S) Each orodispersible tablet contains: 10 mg Olanzapine.
DEKLARATION AV AKTIV(A) SUBSTANS(ER) 1 tablett innehåller: Olanzapin 10 mg.
Olanzapine Teva 5 mg film-coated tablet is a white, biconvex, round film-coated tablet, debossed ”OL 5” on one side and plain on the other.
Olanzapine Teva 5 mg filmdragerade tabletter är vita, bikonvexa, runda, filmdragerade tabletter, präglade med ”OL 5” på en sida och omärkta på den andra.
NAME OF THE MEDICINAL PRODUCT Olanzapine Teva 5 mg orodispersible tablets Olanzapine
LÄKEMEDLETS NAMN Olanzapine Teva 5 mg munlösliga tabletter olanzapin
28 film-coated tablets 28 x 1 film-coated tablets 30 film-coated tablets 30 x 1 film-coated tablets 35 film-coated tablets 35 x 1 film-coated tablets 50 film-coated tablets 50 x 1 film-coated tablets 56 film-coated tablets 56 x 1 film-coated tablets 70 film-coated tablets 70 x 1 film-coated tablets 98 film-coated tablets 98 x 1 film-coated tablets
28 filmdragerade tabletter 28 x 1 filmdragerade tabletter 30 filmdragerade tabletter 30 x 1 filmdragerade tabletter 35 filmdragerade tabletter 35 x 1 filmdragerade tabletter 50 filmdragerade tabletter 50 x 1 filmdragerade tabletter 56 filmdragerade tabletter 56 x 1 filmdragerade tabletter 70 filmdragerade tabletter 70 x 1 filmdragerade tabletter 90 filmdragerade tabletter 90 x 1 filmdragerade tabletter
NAME OF THE MEDICINAL PRODUCT Olanzapine Teva 10 mg film-coated tablets Olanzapine
LÄKEMEDLETS NAMN Olanzapine Teva 10 mg filmdragerade tabletter olanzapin
NAME OF THE MEDICINAL PRODUCT Olanzapine Teva 15 mg film-coated tablets Olanzapine
LÄKEMEDLETS NAMN Olanzapine Teva 15 mg filmdragerade tabletter olanzapin
Olanzapine Teva 5 mg film-coated tablets are available in cartons of 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 70, 70 x 1, 98 or 98 x 1 film-coated tablets.
Olanzapine Teva 5 mg filmdragerade tabletter tillhandahålls i förpackningar med 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 70, 70 x 1, 98 eller 98 x 1 tabletter.
Olanzapine Teva 10 mg film-coated tablets are available in cartons of 7, 7 x 1, 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 or 98 x1 film-coated tablets.
Olanzapine Teva 10 mg filmdragerade tabletter tillhandahålls i förpackningar med 7, 7 x 1, 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 eller 98 x 1 tabletter.
STATEMENT OF ACTIVE SUBSTANCE(S) Each orodispersible tablet contains: 5 mg Olanzapine.
DEKLARATION AV AKTIV(A) SUBSTANS(ER) 1 tablett innehåller: Olanzapin 5 mg.
NAME OF THE MEDICINAL PRODUCT Olanzapine Teva 5 mg film-coated tablets Olanzapine
LÄKEMEDLETS NAMN Olanzapine Teva 5 mg filmdragerade tabletter olanzapin
OPA/alu/PVC-alu blisters in cartons of 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 or 98 x 1 film-coated tablets per carton.
OPA/Aluminium/PVC-aluminium-blisterförpackningar i kartonger om 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 eller 98 x 1 filmdragerade tabletter per kartong.
OPA/alu/PVC-alu blisters in cartons of 7, 7 x 1, 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 or 98 x 1 film-coated tablets per carton.
OPA/Aluminium/PVC-aluminium-blisterförpackningar i kartonger om 7, 7 x 1, 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 eller 98 x 1 filmdragerade tabletter per kartong.
OPA/alu/PVC-alu blisters in cartons of 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 70, 70 x 1, 98 or 98 x 1 film-coated tablets per carton.
OPA/Aluminium/PVC-aluminium-blisterförpackningar i kartonger om 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 70, 70 x 1, 98 eller 98 x 1 filmdragerade tabletter per kartong.
What you need to know before you take Olanzapine Teva 3.
Vad Olanzapine Teva är och vad det används för Vad du behöver veta innan du tar Olanzapine Teva Hur du tar Olanzapine Teva Eventuella biverkningar
Olanzapine Teva 7.5 mg film-coated tablets are available in cartons of 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 or 98 x 1 film-coated tablets.
Olanzapine Teva 7,5 mg filmdragerade tabletter tillhandahålls i förpackningar med 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 eller 98 x 1 tabletter.
Olanzapine Teva 20 mg film-coated tablets are available in cartons of 28, 30, 35, 56, 70 or 98 filmcoated tablets.
Olanzapine Teva 20 mg filmdragerade tabletter tillhandahålls i förpackningar med 28, 30, 35, 56, 70 eller 98 tabletter.
STATEMENT OF ACTIVE SUBSTANCE(S) Each orodispersible tablet contains: 15 mg Olanzapine.
DEKLARATION AV AKTIV(A) SUBSTANS(ER) 1 tablett innehåller: Olanzapin 15 mg.
Olanzapine Teva 2.5 mg film-coated tablets White, biconvex, round film-coated tablets, debossed ”OL 2.5” on one side and plain on the other.
Läkemedlets utseende och förpackningsstorlekar Olanzapine Teva 2,5 mg filmdragerade tabletter är vita, bikonvexa, runda, filmdragerade tabletter, präglade med ”OL 2.5” på en sida och omärkta på den andra.
14 Observed for fasting normal levels at baseline (<1.016 mmol/l) which increased to high
14 Normala värden (<1,016 mmol/l) vid fasta vid studiens början ökade till höga (≥1,467 mmol/l).
Glucosuria Increased appetite
Ökad aptit
Annex I List of medicinal products and presentations
Bilaga I Lista över läkemedel och beredningsformer
Germany Faktor VIII Sdh Intersero
Tyskland Faktor VIII Sdh Intersero
Willebrand Factor
Willebrand-faktor
Belgium Factane 500 IU - 5 ml
Factane 500 IE - 5 ml
Belgium Factane 1000 IU/10 ml
Factane 1 000 IE/10 ml
United Kingdom Alphanate
Nederländerna Alphanate
Haemoctin Biotest Hungaria Kft. Human Coagulation Factor VIII
Haemoctin Biotest Hungaria Kft. Human koagulationsfaktor VIII
Czech Republic Optivate
Nederländerna Optivate
Belgium Wilate
Nederländerna Wilate
Belgium Octanate
Nederländerna Octanate
Instituto Grifols, S.A. Human Coagulation Factor VIII
Instituto Grifols, S.A. Human koagulationsfaktor VIII
Octapharma-Ltd Human Coagulation Factor VIII
Octapharma-Ltd Human koagulationsfaktor VIII
Powder For Injection Intravenous Use
Pulver till injektionsvätska
Lfb Biomedicaments Human Coagulation Factor VIII
LFB Biomedicaments Human koagulationsfaktor VIII
LFB Biomedicaments Human Coagulation Factor VIII
Lfb Biomedicaments Human koagulationsfaktor VIII
Grifols Italia S.P.A Human Coagulation Factor VIII, Human Von Willebrand Factor
Grifols Italia S.P.A Human koagulationsfaktor VIII, human von Willebrandfaktor
Octapharma France Human Coagulation Factor VIII
Octapharma France Human koagulationsfaktor VIII
Octanate LV Octapharma France Human Coagulation Factor VIII
Octanate LV Octapharma France Human koagulationsfaktor VIII
Octapharma-Ltd Human Coagulation Factor VIII, Human Von Willebrand Factor
Octapharma-Ltd Human koagulationsfaktor VIII, human von Willebrandfaktor
Octapharma Ab Human Coagulation Factor VIII
Octapharma Ab Human koagulationsfaktor VIII
Instituto Grifols, S.A. Human Coagulation Factor VIII, Human Von Willebrand Factor
Instituto Grifols, S.A. Human koagulationsfaktor VIII, von Willebrand-faktor
Intersero Gmbh Human Coagulation Factor VIII
Intersero Gmbh Human koagulationsfaktor VIII
Human Coagulation Factor VIII 1000 I.E. Human Von Willebrand Factor 2400 I.E.
Human koagulationsfaktor VIII 1 000 IE human von Willebrand-faktor 2 400 IE
Octapharma Gmbh Human Coagulation Factor VIII
Octapharma Gmbh Human koagulationsfaktor VIII
Octanate Lv Octapharma Ab Human Coagulation Factor VIII
Octanate Lv Octapharma Ab Human koagulationsfaktor VIII
Octanate 1000 Octapharma Gmbh Human Coagulation Factor VIII
Octanate 1000 Octapharma Gmbh Human koagulationsfaktor VIII
Octapharma Ab Human Coagulation Factor VIII, Human Von Willebrand Factor
Octapharma Ab Human koagulationsfaktor VIII, human von Willebrandfaktor
Octanate 250 Octapharma Gmbh Human Coagulation Factor VIII
Octanate 250 Octapharma Gmbh Human koagulationsfaktor VIII
Powder And Solvent For Solution For Infusion
Pulver och vätska till infusionsvätska, lösning
United Kingdom Octanate Lv Octapharma-Ltd Human Coagulation Factor VIII
Octanate Lv Octapharma-Ltd Human koagulationsfaktor VIII
Human Coagulation Factor VIII 500 I.E., Human Von Willebrand Factor 300 I.E.
Human koagulationsfaktor VIII 500 IE, human von Willebrand-faktor 300 IE
Human Coagulation Factor VIII 250 I.E., Human Von Willebrand Factor 600 I.E.
Human koagulationsfaktor VIII 250 IE, human von Willebrand-faktor 600 IE
Wilate 450 Octapharma Gmbh Human Coagulation Factor VIII, Human Von
Wilate 450 Octapharma Gmbh Human koagulationsfaktor VIII, human von Willebrandfaktor
Octanate 500 Octapharma Gmbh Human Coagulation Factor VIII
Octanate 500 Octapharma Gmbh Human koagulationsfaktor VIII
Human Coagulation Factor VIII 500 I.E., Human Von Willebrand Factor 1200 I.E.
Human koagulationsfaktor VIII 500 IE, human von Willebrand-faktor 1 200 IE
Beriate 2000 Csl Behring Gmbh Human Coagulation Factor VIII
Beriate 2000 Csl Behring Gmbh Human koagulationsfaktor VIII
Octapharma Gmbh Human Coagulation Factor VIII, Human Von Willebrand Factor
Octapharma Gmbh Human koagulationsfaktor VIII, human von Willebrandfaktor
Human Coagulation Factor VIII 250 I.E. Human Von Willebrand Factor 150 I.E.
Human koagulationsfaktor VIII 250 IE, human von Willebrand-faktor 150 IE
Beriate 500 Csl Behring Gmbh Human Coagulation Factor VIII
Beriate 500 Csl Behring Gmbh Human koagulationsfaktor VIII
CSL Behring Gmbh Human Coagulation Factor VIII
Csl Behring Gmbh Human koagulationsfaktor VIII
Csl Behring Gmbh Human Coagulation Factor VIII
CSL Behring Gmbh Human koagulationsfaktor VIII
Beriate 250 Csl Behring Gmbh Human Coagulation Factor VIII
Beriate 250 Csl Behring Gmbh Human koagulationsfaktor VIII
Csl Behring Gmbh Human Coagulation Factor VIII, Human Von Willebrand Factor
Csl Behring Gmbh Human koagulationsfaktor VIII (rDNA), human von Willebrand-faktor
Aafact
Nederländerna Aafact
Beriate 1000 Csl Behring Gmbh Human Coagulation Factor VIII
Beriate 1000 Csl Behring Gmbh Human koagulationsfaktor VIII
Wilate 900 Octapharma Gmbh Human Coagulation Factor VIII, Human Von
Wilate 900 Octapharma Gmbh Human koagulationsfaktor VIII, human von Willebrandfaktor
Human Coagulation Factor VIII 1000 IU
Human koagulationsfaktor VIII 1 000 IE Injektionsflaska
Wilate 1000 Octapharma Gmbh Human Coagulation Factor VIII, Human Von
Wilate 1000 Octapharma Gmbh Human koagulationsfaktor VIII, human von Willebrandfaktor
Human Coagulation Factor VIII 500IU/Vial, Human Von Willebrand Factor 120 I.U.
Human koagulationsfaktor VIII 50 IE /ml, von Willebrand-faktor 120 IE /ml
Wilate 500 Octapharma Gmbh Human Coagulation Factor VIII, Human Von
Wilate 500 Octapharma Gmbh Human koagulationsfaktor VIII, human von Willebrandfaktor
Human Coagulation Factor VIII (Rdna) 1000IU/Vial
Human koagulationsfaktor VIII (rDNA) 1 000 IE /10 ml
Haemate P Csl Behring, S.A Human Coagulation Factor VIII, Von
Haemate P Csl Behring, S.A Human koagulationsfaktor VIII, von Willebrand-faktor
Haemate P Csl Behring Gmbh Human Coagulation Factor VIII (Rdna),
Haemate P Csl Behring Gmbh Human koagulationsfaktor VIII (rDNA), human von
Human Coagulation Factor VIII 100 I.U./ml, Human Von Willebrand Factor 100 I.U./ml VIII
Human koagulationsfaktor VIII 100 IE /ml, von Willebrand-faktor 25 IE /ml
United Kingdom 8y
Förenade Kungariket (Storbritannien)
Haemate P Csl Behring Mepe Human Coagulation Factor VIII, Human Von
Haemate P Csl Behring Mepe Human koagulationsfaktor VIII, human von Willebrandfaktor
Human Coagulation Factor VIII (Rdna) 200 I.U.
Human koagulationsfaktor VIII (rDNA) 200 IE /ml
Human Coagulation Factor VIII 1000 I.E./ Human Von Willebrand Factor 600 I.E.
Human koagulationsfaktor VIII 1 000 IE, human von Willebrand-faktor 600 IE
/ ml, Human Von Willebrand Factor 120 I.U.
IE/injektionsflaska, human von Willebrand-faktor 120 IE /ml
Human Coagulation Factor VIII (Rdna) 500IU/Vial
Human koagulationsfaktor VIII (rDNA) 500 IE /5 ml
Human Coagulation Factor VIII 100 IU/ml
Human koagulationsfaktor VIII (rDNA) 100 IE /ml
Belgium Recombinate Baxalta Innovations Gmbh
Nederländerna Recombinate Baxalta Innovations Gmbh
Human Coagulation Factor VIII (Rdna) 25 I.U.
Human koagulationsfaktor VIII (rDNA) 25 IE /ml
Human Coagulation Factor VIII (Rdna) 50 I.U.
Human koagulationsfaktor VIII (rDNA) 50 IE /ml
Human Coagulation Factor VIII (Rdna) 1000 I.U.
Human koagulationsfaktor VIII (rDNA) 1 000
Human Coagulation Factor VIII (Rdna) 250IU/Vial
Human koagulationsfaktor VIII (rDNA) 250 IE /5 ml
Octanate Lv Octapharma Gmbh Human Coagulation Factor VIII
Nederländerna Octanate Lv Octapharma Gmbh Human koagulationsfaktor VIII
Haemate P Csl Behring Gmbh Human Coagulation Factor VIII, Human Von
Haemate P Csl Behring Gmbh Human koagulationsfaktor VIII, human von Willebrandfaktor
Human Coagulation Factor VIII (Rdna) 66.6 I.U.
Human koagulationsfaktor VIII (rDNA) 66,6 IE /ml, human von Willebrandfaktor 160 IE /ml
Cardboard box 1 vial of freezedried antigen and 1 vial of aqueous adjuvant
1 injektionsflaska med frystorkat antigen och 1 injektionsflaska med vattnigt adjuvans
Trade name Strength Pharmaceutical Form
EU:s aktnummer Fantasinamn Styrka Läkemedelsform Djurslag Administreringssätt
Date of first authorisation: 24 June 2016
Datum för det första godkännandet: 24 juni 2016
HDPE bottles: 3 years Blisters: 5 years
HDPE-flaskor: 3 år Blister: 5 år
This will help the doctor identify what you have taken.
Detta hjälper läkaren att identifiera vad du har tagit.
There is no known specific antidote.
Det finns ingen känd specifik antidot.
The capsules are packaged in bottles or blisters.
Kapslarna är förpackade i flaskor eller blister.
The magnitude of this effect is not considered to be of clinical relevance.
Storleken på den här effekten anses inte ha klinisk relevans.
Children and adolescents under the age of 18 years must not take this medicine as it has not been studied in these age groups.
Barn och ungdomar under 18 år får inte ta detta läkemedel eftersom det inte har studerats på den här åldersgruppen.
There are no or limited amount of data from the use of opicapone in pregnant women.
Det finns inga eller begränsad mängd data från användningen av opikapon i gravida kvinnor.
Follow the instructions that your doctor has given you.
Följ anvisningarna du har fått av läkaren.
At screening, the mean age was similar in all treatment groups in both studies, ranging between 61.5 and 65.3 years.
Vid screening var medelåldern lika i alla behandlingsgrupperna i båda studierna, mellan 61,5 och 65,3 år.
Caution must be exercised in patients ≥ 85 years of age as there is limited experience in this age group.
Försiktighet måste iakttas hos patienter ≥ 85 år eftersom erfarenheten är begränsad hos denna åldersgrupp.
Your doctor may need to reconsider your treatment.
Läkaren kan behöva ompröva din behandling.